Cargando…

Autoantibodies from SLE patients induce programmed cell death in murine fibroblast cells through interaction with TNFR1 receptor

Various pathological processes are known to be associated with the production of IgG autoantibodies, which have high affinity for self-antigens and often cause tissue injury and the development of autoimmune diseases. However, the mechanism of their cytotoxic activity is not clearly understood yet....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharapova, Tatiana N., Romanova, Elena A., Soshnikova, Natalia V., Belogurov, Alexey A., Lomakin, Yakov A., Sashchenko, Lidia P., Yashin, Denis V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340778/ https://www.ncbi.nlm.nih.gov/pubmed/32636466 http://dx.doi.org/10.1038/s41598-020-68088-x

Ejemplares similares

Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors
por: Sharapova, Tatiana N., et al.
Publicado: (2021)

A 8-mer Peptide of PGLYRP1/Tag7 Innate Immunity Protein Binds to TNFR1 Receptor and Inhibits TNFα-Induced Cytotoxic Effect and Inflammation
por: Telegin, Georgii B., et al.
Publicado: (2021)

Hsp70 Interacts with the TREM-1 Receptor Expressed on Monocytes and Thereby Stimulates Generation of Cytotoxic Lymphocytes Active against MHC-Negative Tumor Cells
por: Sharapova, Tatiana N., et al.
Publicado: (2021)

Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor
por: Yurkina, Daria M., et al.
Publicado: (2023)

Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity
por: Sharapova, T. N., et al.
Publicado: (2018)

Cytokines TNFα, IFNγ and IL-2 Are Responsible for Signal Transmission from the Innate Immunity Protein Tag7 (PGLYRP1) to Cytotoxic Effector Lymphocytes
por: Sharapova, Tatiana N., et al.
Publicado: (2020)

N-Terminal Peptide of PGLYRP1/Tag7 Is a Novel Ligand for TREM-1 Receptor
por: Sharapova, Tatiana N., et al.
Publicado: (2022)

Tag7-Mts1 Complex Induces Lymphocytes Migration via CCR5 and CXCR3 Receptors
por: Sharapova, T. N., et al.
Publicado: (2018)

Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface
por: Ivanova, O. K., et al.
Publicado: (2023)

Tag7–Mts1 Complex Activates Chemotaxis of Regulatory T Cells
por: Ivanova, O. K., et al.
Publicado: (2022)

Short Peptides of Innate Immunity Protein Tag7 Inhibit the Production of Cytokines in CFA-Induced Arthritis
por: Telegin, Georgii B., et al.
Publicado: (2022)

A 12-mer Peptide of Tag7 (PGLYRP1) Forms a Cytotoxic Complex with Hsp70 and Inhibits TNF-Alpha Induced Cell Death
por: Romanova, Elena A., et al.
Publicado: (2020)

Autoantibodies in SLE: Specificities, Isotypes and Receptors
por: Dema, Barbara, et al.
Publicado: (2016)

Autoantibody-dependent amplification of inflammation in SLE
por: Lou, Hantao, et al.
Publicado: (2020)

Persistent expression of autoantibodies in SLE patients in remission
por: Yurasov, Sergey, et al.
Publicado: (2006)

MHC associations with clinical and autoantibody manifestations in European SLE
por: Morris, DL, et al.
Publicado: (2014)

Exhaustive Search of the Receptor Ligands by the CyCLOPS (Cytometry Cell-Labeling Operable Phage Screening) Technique
por: Ishina, Irina A., et al.
Publicado: (2020)

Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity
por: Yashin, D. V., et al.
Publicado: (2021)

Regulatory natural autoantibodies suppress inflammation and SLE disease activity
por: Silverman, GJ, et al.
Publicado: (2012)

Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state
por: Skvortsova, Elena V., et al.
Publicado: (2018)

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
por: Ko, Kichul, et al.
Publicado: (2013)

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease
por: Giordano, Daniela, et al.
Publicado: (2023)

Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients
por: Lomakin, Yakov, et al.
Publicado: (2016)

CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia
por: Wu, Boting, et al.
Publicado: (2015)

Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
por: Merrill, Joan T, et al.
Publicado: (2018)

A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
por: Laurynenka, Viktoryia, et al.
Publicado: (2022)

TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
por: Rauert, H, et al.
Publicado: (2011)

Microparticles as antigenic targets in human and murine SLE
por: Ullal, Anirudh, et al.
Publicado: (2012)

IFNα Inducible Models of Murine SLE
por: Liu, Zheng, et al.
Publicado: (2013)

Design of Targeted B Cell Killing Agents
por: Stepanov, Alexey V., et al.
Publicado: (2011)

Targeted killing of TNFR2-expressing tumor cells and T(regs) by TNFR2 antagonistic antibodies in advanced Sézary syndrome
por: Torrey, H, et al.
Publicado: (2018)

The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
por: Takahashi, Hiroyuki, et al.
Publicado: (2022)

Polyreactive Monoclonal Autoantibodies in Multiple Sclerosis: Functional Selection from Phage Display Library and Characterization by Deep Sequencing Analysis
por: Lomakin, Y. A., et al.
Publicado: (2013)

Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
por: Siegmund, Daniela, et al.
Publicado: (2016)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
por: Wajant, Harald, et al.
Publicado: (2019)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2023)

Distinct Role of TNFR1 and TNFR2 in Protective Immunity Against Orientia tsutsugamushi Infection in Mice
por: Liang, Yuejin, et al.
Publicado: (2022)

Comparison of different immunoassays detecting anti-chromatin autoantibodies in systemic lupus erythematosus (SLE)
por: Roux-Lombard, P, et al.
Publicado: (2002)

Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies
por: Irure-Ventura, Juan, et al.
Publicado: (2022)

Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections
por: Ruiz, Andy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pnaaglbl6h557bea9had3k2bf